Naloxone is an effective FDA-approved opioid antagonist for reversing opioid overdoses.
Naloxone is available to the public and can be administered through intramuscular (IM) …

Issues To date, there has been no synthesis of research addressing the scale and nuances
of the opioid epidemic in racial/ethnic minority populations in the United States that …

Background Rates of synthetic opioid-related deaths over time and across regions have
been compared within the US, but other indicator data could help inform prevention and …

Abstract Background Overdose prevention centers (OPCs) are being implemented in the
United States as a strategy to reduce drug-related mortality and morbidity. Previous studies …

Background Opioid withdrawal symptoms (OWS) are highly aversive and prompt
unprescribed opioid use, which increases morbidity, mortality, and, among individuals being …

Background Persons who inject drugs (PWID) may be unengaged with healthcare services
and face an elevated risk of severe morbidity and mortality associated with COVID-19 due to …

Background The rising prevalence of fast-acting opioids in the USA suggests the increased
need for non-professional first responder administration of naloxone. Effective administration …

Background: Overdose deaths continue to reach new records in New York City and
nationwide, largely driven by adulterants such as fentanyl and xylazine in the illicit drug …

Background Significant heterogeneity exists among people who use drugs (PWUD). We
identify distinct profiles of syringe service program (SSP) clients to (a) evaluate differential …

Background: Fentanyl has emerged as the leading cause of fatal drug overdoses in the US
Individuals misusing drugs may not always be aware of exposure to fentanyl. Objectives: To …